rs199473513
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PM5PP3_StrongPP5_Moderate
The NM_000238.4(KCNH2):c.1502A>G(p.Asp501Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D501H) has been classified as Pathogenic.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.1502A>G | p.Asp501Gly | missense_variant | 6/15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.1502A>G | p.Asp501Gly | missense_variant | 6/15 | 1 | NM_000238.4 | ENSP00000262186.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 40
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 24, 2012 | p.Asp501Gly (GAC>GGC):c.1502 A>G in exon 6 of the KCNH2 gene (NM_000238.2)The Asp501Gly mutation in the KCNH2 gene has been reported previously in association with LQTS (Goldenberg I et al., 2011). In addition, the NHLBI ESP Exome Variant Server reports Asp501Gly was not observed in approximately 6,000 samples from individuals of European and African American backgrounds, indicating it is not a common benign variant in these populations. Asp501Gly results in a non-conservative amino acid substitution of a negatively charged Aspartic acid with a non-polar Glycine at a residue that is conserved across species. Different mutations at the same codon (Asp501His, Asp501Asn) as well as mutations in a nearby codon (Tyr493Cys, Tyr493Phe, Tyr493Ser) have also been reported in association with LQTS, further supporting the functional importance of this region of the protein.In summary, Asp501Gly in the KCNH2 gene is interpreted as a disease-causing mutation. The variant is found in LQT panel(s). - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19926013). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at